Population pharmacokinetics of lenalidomide in multiple myeloma patients

Author(s):: Guglieri-Lopez, B.; Perez-Pitarch, A.; Moes, D.J.A.R. (0000-0003-3219-253X); Porta-Oltra, B.; Climente-Marti, M.; Guchelaar, H.J. (0000-0002-7085-1383); Merino-Sanjuan, M.

Published: 2017
Publication type: Article / Letter to editor

LenalidomideMultiple myelomaPopulation pharmacokineticsPersonalized medicine

Date issued: 2017-01-31
Language: English
Is part of: Cancer Chemotherapy and Pharmacology (2017), Vol. 79, no. 1, p. 189-200
hdl: 1887/113126
doi: 10.1007/s00280-016-3228-y